Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 4 (1)

Trial Status

Withdrawn1
Recruiting1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07154667Not ApplicableRecruitingPrimary

Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction

NCT03729427Not ApplicableWithdrawnPrimary

Rib Microtia and the Erector Spinae Plane (ESP) Block

NCT04192708Phase 4Unknown

Study of Analgesic Efficacy of Nerve Blocks on Otoplastic Surgery

Showing all 3 trials

Research Network

Activity Timeline